Measures for control of influenza

PharmacoEconomics

Volumn 16, Issue SUPPL. 1, 1999, Pages 41-45

  Couch, Robert B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

CONFERENCE PAPER; DRUG EFFICACY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NEUROTOXICITY; PRIORITY JOURNAL; RISK MANAGEMENT;

EID: 0032735778     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916001-00006     Document Type: Conference Paper

References (19)

1. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998; 47(RR-6): 1-26
2. Couch RB, Quarles JM, Cate TR, et al. Clinical trials with live cold-reassortant influenza virus vaccines. In: Kendal AP, Patriarca PA, editors. Options for the control of influenza UCLA Symposia on Molecular and Cellular Biology; Vol. 36, New York: Alan R Liss, 1986: 223-41
3. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J Infect Dis 1997; 176 Suppl. 1: S38-44
4. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253: 1136-9
5. Maassab HF. Adaptation and growth characteristics of influenza virus at 25°C. Nature 1967; 213: 612-4
6. Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169: 68-76
7. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338: 1405-12
8. Treanor JJ, Mattison HR, Dumyati G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992; 117: 625-33
9. Dolin R, Reichman RC, Madore HP, et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307 (10): 580-4
10. Clover RD, Crawford SA, Abell TD, et al. Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child 1986; 140: 706-9
11. Van Voris LP, Betts RF, Hayden FG, et al. Successful treatment of naturally occurring influenza A/USSR/77 HINI. JAMA 1981; 245: 1128-31
12. Couch RB, Kasel JA, Glezen WP, et al. Influenza: its control in persons and populations. J Infect Dis 1986; 153 (3): 431-40
13. Knight V, Gilbert B. Antiviral therapy with small particle aerosols. Eur J Clin Microb Infect Dis 1988; 7 (6): 721-31
14. Hayden FG, Atmar R, Schilling M, et al. Safely and efficacy of oral GS4104 in long term prophylaxis of natural influenza [abstract no. LB-6]. Final Programme, Abstracts and Exhibits Addendum of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sep 24-27: San Diego, CA: American Society for Microbiology, 1998: 22
15. Monto AS, Robinson DP, Herlocher L, et al. Efficacy and safety of zanamivir in prevention of influenza among healthy adults [abstract no. LB-7]. Final Programme, Abstracts and Exhibits Addendum of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sep 24-27: San Diego, CA: American Society for Microbiology, 1998: 22
16. Hayden FG, Osterhaus ADME, Treanor J, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337: 874-80
17. Treanor JJ, Vrooman PS, Hayden FB, et al. Efficacy of oral GS4104 in treating acute influenza [abstract no. LB-4]. Final Programme, Abstracts and Exhibits Addendum of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sep 24-27: San Diego, CA: American Society for Microbiology, 1998: 21
18. Silagy CA, Campion KJ, Keene O. The efficacy and safety of zanamivir in the treatment of influenza in otherwise healthy and 'high risk' individuals [abstract no. H-56]. Final Programme, Abstracts and Exhibits Addendum of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sep 24-27: San Diego, CA: American Society for Microbiology, 1998: 331
19. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978; 298: 587-92